Tuesday, November 10, 2020
-
The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies (ABC, ADPT, AFMD, ALC, ALGS, ALT, APVO, ARNA, ARPO, AVIR, BDSX, BIIB, BIO, Biotech, BLCM, BLFS, BMY, BNTX, BVXV, CALT, CCCC, CLPT, CLSD, CPIX, CRBP, CRIS, CTIC, CTLT, DMTK, DNLI, DTIL, Earnings, EYEN, FATE, FLGT, FULC, GLMD, GMDA, GOSS, HALO, HRMY, HTGM, IBB, IMVT, INSP, ISRG, KALV, KOD, KRMD, KURA, KYMR, LLY, LRMR, LUMO, LXRX, MDWD, MMSI, MNPR, MRK, NBIX, NBRV, News, NK, NTLA, NVAX, NVRO, OCUL, OCUP, OSMT, PACB, PASG, Penny Stocks, PFE, PODD, PTCT, PTE, QLGN, RARE, RMD, RVNC, SILK, SSKN, STIM, STOK, STRO, SUPN, SWAV, SYN, TCON, TCRR, TECH, TWST, TXG, TXMD, VCEL, VCYT, VIE, WST, YMAB, ZGNX, Guidance, Offerings, Small Cap, FDA / Tue, 09:40am)
Tuesday, September 17, 2019
-
The Daily Biotech Pulse: Acceleron Shelves Muscular Dystrophy Drug Trial, Aclaris Aces Late-Stage Study (ACAD, ACRS, ALC, ALDR, AXSM, Biotech, BNGO, CTXR, DMTK, HSDT, IBB, KOD, LXRX, MDCO, MITO, MYOV, News, NTRA, NVS, TNXP, VIVE, XBI, XLRN, YMAB, ZEAL, Offerings, Top Stories, Pre-Market Outlook, Trading Ideas / Tue, 07:23am)
Thursday, May 09, 2019
-
The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut (ABUS, ADMP, ADMS, AGEN, AKBA, ALBO, ALC, ALDX, AMPH, AMRX, APHB, APOP, AQST, ATNX, ATRA, AXDX, AXSM, Biotech, BLFS, BSGM, BTX, CALA, CATB, CDMO, CDNA, CHMA, CHRS, CMRX, CORT, CRBP, CRVS, CTMX, DRNA, Earnings, ELAN, ELOX, ENDP, FGEN, FLXN, GH, GTHX, HTGM, IBB, ICPT, ICUI, IMMU, INO, IONS, ITMR, KALA, KIN, KPTI, M&A, MLNT, MRSN, MYOK, NBY, NEOS, News, NTRA, NVRO, NVS, OBSV, OPK, OPNT, OPTN, OSMT, OXFD, PBYI, PDLI, PFNX, PHAS, PRVB, RETA, RMTI, RTRX, RVNC, SELB, SPPI, SRTS, SWAV, SYBX, SYNH, TAK, TRXC, URGN, VIVE, VSTM, XBI, XLRN, XNCR, Offerings, FDA, IPOs, Pre-Market Outlook, Trading Ideas, General / Thu, 07:56am)
Thursday, May 02, 2019
-
The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data (ABMD, ACOR, ADAP, AGIO, ALC, ALDR, ANIK, APVO, ATNX, ATRS, AZN, BIIB, Biotech, BTX, CLBS, CNCE, Earnings, EARS, EBS, ELGX, EVLO, EYEG, GILD, GLYC, GMED, HBIO, HRTX, IBB, IRWD, KMPH, LGND, MGTA, News, NTLA, NVAX, NVCR, NVTR, OPNT, PCRX, PMD, PODD, PTCT, SAGE, SBBP, SNY, TTOO, VCYT, VKTX, XBI, Offerings, FDA, Top Stories, Pre-Market Outlook, Trading Ideas / Thu, 08:16am)
Friday, April 12, 2019
-
The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug (ABMD, ACOR, AKRX, ALBO, ALC, ALT, Biotech, CNCE, DTIL, Earnings, EDAP, EIGR, HSDT, IBB, KMPH, MRK, News, NVS, OTLK, RVNC, SBPH, SCPH, TEVA, TLGT, VIVE, VXRT, XBI, XFOR, Offerings, FDA, Top Stories, Pre-Market Outlook, Trading Ideas / Fri, 07:47am)
